Literature DB >> 11354914

Adjunctive use of chlorhexidine in oral candidoses: a review.

A N Ellepola1, L P Samaranayake.   

Abstract

Oral candidosis is by far the commonest human fungal infection and manifests in a variety of clinical guises. The main reason for its high incidence appears to be the multiplicity of predisposing factors, which facilitate the conversion of oral commensal Candida to a parasitic existence. Despite the availability of a number of effective antimycotics for the treatment of oral candidoses, failure of therapy is not uncommon owing to the unique environment of the oral cavity where the flushing effect of saliva and the cleansing action of the oral musculature tend to reduce the drug concentration to sub-therapeutic levels. For these and other reasons chlorhexidine is widely prescribed in dentistry both as an antiseptic mouthwash and a denture disinfectant in order to supplement other antifungals. Chlorhexidine has a broad spectrum of antimicrobial activity including Candida albicans and other common non-albicans yeast species. In this review we outline the utility of chlorhexidine as an adjunct to conventional antimycotic therapy in the management of oral Candida infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354914

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  19 in total

Review 1.  Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011.

Authors:  Rene-Jean Bensadoun; Lauren L Patton; Rajesh V Lalla; Joel B Epstein
Journal:  Support Care Cancer       Date:  2011-04-10       Impact factor: 3.603

2.  Oral candidosis in lichen planus: the diagnostic approach is of major therapeutic importance.

Authors:  C Kragelund; L Kieffer-Kristensen; J Reibel; E P Bennett
Journal:  Clin Oral Investig       Date:  2012-06-15       Impact factor: 3.573

Review 3.  MASCC/ISOO expert opinion on the management of oral problems in patients with advanced cancer.

Authors:  Jac A Jones; Yanin Chavarri-Guerra; Luisa Barreto Costa Corrêa; David R Dean; Joel B Epstein; Eduardo R Fregnani; Jiyeon Lee; Yuhei Matsuda; Valeria Mercadante; Ragnhild Elisabeth Monsen; Natasja J H Rajimakers; Deborah Saunders; Enrique Soto-Perez-de-Celis; Mariana S Sousa; Arghavan Tonkaboni; Arjan Vissink; Keng Soon Yeoh; Andrew N Davies
Journal:  Support Care Cancer       Date:  2022-06-18       Impact factor: 3.603

4.  Glass fibre-reinforced composite laced with chlorhexidine digluconate and yeast adhesion.

Authors:  T Waltimo; G Luo; L P Samaranayake; P K Vallittu
Journal:  J Mater Sci Mater Med       Date:  2004-02       Impact factor: 3.896

5.  A randomized clinical trial of chlorhexidine in the maintenance of oral candidiasis-free period in HIV infection.

Authors:  W Nittayananta; T A DeRouen; P Arirachakaran; T Laothumthut; K Pangsomboon; S Petsantad; V Vuddhakul; H Sriplung; S Jaruratanasirikul; M D Martin
Journal:  Oral Dis       Date:  2008-06-21       Impact factor: 3.511

Review 6.  A comparative, randomized, controlled study on clinical efficacy and dental staining reduction of a mouthwash containing Chlorhexidine 0.20% and Anti Discoloration System (ADS).

Authors:  Massimo Marrelli; Massimiliano Amantea; Marco Tatullo
Journal:  Ann Stomatol (Roma)       Date:  2015-07-28

7.  Preparation, in vitro characterization and preliminary in vivo evaluation of buccal polymeric films containing chlorhexidine.

Authors:  Claudia Juliano; Massimo Cossu; Paola Pigozzi; Giovanna Rassu; Paolo Giunchedi
Journal:  AAPS PharmSciTech       Date:  2008-11-19       Impact factor: 3.246

8.  Differential actions of chlorhexidine on the cell wall of Bacillus subtilis and Escherichia coli.

Authors:  Hon-Yeung Cheung; Matthew Man-Kin Wong; Sau-Ha Cheung; Longman Yimin Liang; Yun-Wah Lam; Sung-Kay Chiu
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

9.  Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan.

Authors:  Mohammad H Al-Shayyab; Osama A Abu-Hammad; Mahmoud K Al-Omiri; Najla S Dar-Odeh
Journal:  Int Dent J       Date:  2015-07-07       Impact factor: 2.607

10.  Chlorhexidine: beta-cyclodextrin inhibits yeast growth by extraction of ergosterol.

Authors:  K I R Teixeira; P V Araújo; R D Sinisterra; M E Cortés
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.